Dizhe Pharmaceutical (688192.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved an operating income of 8...
According to Zhitong Finance App News, Dizhe Pharmaceutical (688192.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 81.386 million yuan; net loss attributable to shareholders of listed companies of 224 million yuan; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss of 255 million yuan; and a basic loss of 0.54 yuan per share.